Consequently, YAP nuclear translocation is suppressed, leading to reduced transcription of downstream targets CTGF and CYR61, ultimately exerting a robust inhibitory effect on NSCLC cell proliferation, migration, and tumor growth. This evidence concerns the gene YAP1 and non-small cell lung carcinoma.